Fennec Pharmaceuticals (TSE:FRX) Share Price Passes Below 50 Day Moving Average – Should You Sell?

Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of C$9.40 and traded as low as C$9.21. Fennec Pharmaceuticals shares last traded at C$9.21, with a volume of 201 shares.

Fennec Pharmaceuticals Price Performance

The stock has a market cap of C$177.61 million, a P/E ratio of -156.02 and a beta of 0.25. The company has a current ratio of 7.80, a quick ratio of 10.17 and a debt-to-equity ratio of -620.83. The company’s fifty day simple moving average is C$9.40 and its 200-day simple moving average is C$8.09.

Insider Activity

In other Fennec Pharmaceuticals news, Director Rostislav Christov Raykov sold 10,000 shares of the stock in a transaction on Monday, January 6th. The stock was sold at an average price of C$8.76, for a total transaction of C$87,552.00. In the last three months, insiders have sold 21,186 shares of company stock worth $196,017. Corporate insiders own 16.20% of the company’s stock.

About Fennec Pharmaceuticals

Fennec Pharmaceuticals Inc operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons.